Leaders in Pharmaceutical Business Intelligence (LPBI) Group

14th Annual BioPharma & Healthcare Summit, Friday, September 4, 2020, 8 AM EST to 3-30 PM EST – Virtual Edition

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

Founder & Director, LPBI Group

 

 

 

LPBI’s 2020 VISION

@pharma_BI

@AVIVA1950

 

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

In these unprecedented times due to COVID-19, USAIC is offering Free Registration for its annual summit.

Click for free registration

 

AGENDA & SPEAKERS

Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals
Summit Theme: “From N of One to N of a Billion”

• Moderated Fireside Chat- Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co. and Stelios Papadopoulos, Chairman of the Board, Biogen
• Moderated Fireside Chat- Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals and Mathai Mammen, Global Head of R&D, Janssen Pharmaceutical Companies of Johnson & Johnson
• Moderated Fireside Chat- K. VijayRaghavan, Principal Scientific Advisor, Government of India and Amitabh Kant, CEO, National Institution for Transforming India (NITI)

Panel Discussions:

• Covid-19: Where are we now? Where are we going?
• Oncology: A never ending tunnel?
• Rare Diseases: Breaking Barriers for a Healthy Brain
• Digital & Data Sciences: Leveraging data and digital to achieve healthcare solutions
• Industry & Investment Outlook
• R&D Strategies and Trends: Innovation – The Big I

Program and speakers subject to change^*

14th Annual BioPharma & Healthcare Summit, Friday, September 4, 2020, 8 AM EST to 3-30 PM EST – Virtual Edition Speakers Registration Agenda Speakers Kenneth Frazier Chairman of the Board & CEO Merck & Co. Dr. Andrew Plump President of R&D Takeda Pharmaceuticals Dr. Laurie Glimcher President & CEO Dana-Farber Cancer Institute Dr. Roy Vagelos Chairman of the Board Regeneron Dr. Stelios Papadopoulos Chairman of the Board Biogen Christopher Viehbacher Managing Partner Gurnet Point Capital Dr. Mathai Mammen Global Head of R&D Janssen- Johnson & Johnson Kiran Mazumdar Shaw Chairperson & Managing Director Biocon Dr. Hal Barron President, R&D and CSO GlaxoSmithKline Prof. K. Vijay Raghavan Principal Scientific Advisor Government of India Dr. George Yancopoulos Co-Founder, President & CSO Regeneron Dr. Elias Zerhouni Professor Emeritus Johns Hopkins University Daphne Zohar Founder & CEO PureTech Health Sanat Chattopadhyay President- Merck Manufacturing Division Merck & Co. Dr. David Reese Executive Vice President- R&D Amgen Hari Bhartia Founder & Co-Chairman Jubilant Bhartia Group Dr. Alfred Sandrock Exe Vice President R&D & CMO Biogen Dr. Najat Khan Chief Operating Officer, Data Sciences Janssen- Johnson & Johnson Dr. Richard Hatchett Chief Executive Officer CEPI Amitabh Kant Chief Executive Officer NITI Aayog Dr. Martin Mackay Co-Founder Rallybio Dr. Daniel Curran Head of the Rare Diseases TA Takeda Pharmaceuticals Dr. Alise Reicin Former President, Global Clinical Dev. Celgene Dr. David Meeker Chairman & CEO Rhythm Pharmaceuticals Dr. John Orloff EVP and Head of R&D Alexion Dr. Barry Bloom Professor & former Dean Harvard School of Public Health Dr. Mandeep Bhandari Joint Secretary Ministry of Health, India Arpa Garay President, Commercial Analytics Merck & Co. Dr. Steve Uden Co-Founder Rallybio Dr. Philip Larsen Global Head of Research Bayer AG Sastry Chilukuri Executive Vice President Medidata Dr. William Chin Professor of Medicine, Emeritus Harvard Medical School Dr. Anne Heatherington Head of Data Sciences Institute Takeda Pharmaceuticals Dr. V G Somani Drugs Controller General of India Government of India Dr. Rajeev Venkayya President-Global Vaccines Takeda Dr. Raju Kucherlapati Professor of Genetics Harvard Medical School Matt Wilsey Co-Founder & Chairman Grace Science Foundation Muna Bhanji SVP, Global Market Access Merck & Co. Dr. Maya Said Chief Executive Officer Outcomes4Me Rehan Verjee President EMD Serono

SOURCE:

https://usaindiachamber.org/speaker.php